Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa

Frontiers in Immunology(2022)10.3389/fimmu.2022.959697Source: DataRank Database

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.39)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Issaka Sagara ORCID,Halimatou Diawara ORCID,Mahamadoun H. Assadou,Abdoulaye Katilé ORCID,Oumar Attaher

Live enrichment

PubMed:35990648 PMC:PMC9382593 OpenAlex:https://openalex.org/W4289545203

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: RIA2018SV-2311

European & Developing Countries Clinical Trials Partnership (EDCTP)

National Institutes of Health

FWCI

0.39

Citation Percentile

0.6%

Citation Trend

2022

2024

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.959697/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.959697/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.959697/full

journalhttps://doi.org/10.3389/fimmu.2022.959697

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35990648

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMosquito-borne diseases and control

MeSH Terms

COVID-19Antibody FormationHumansMalariaMaliParasitemiaAsymptomatic InfectionsPandemics

Keywords

SeroconversionParasitemiaMalariaAsymptomaticMedicineTransmission (telecommunications)VirologyCumulative incidenceIncidence (geometry)Tropical medicineImmunologyCohortInternal medicinePlasmodium falciparumVirusPathologySerologySeverityFalciparumWest AfricaCovid-19

Sustainable Development Goals

SDG 0: Good health and well-being

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa

FAIR Checklist

Authors (24)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)